About
Christina Kuhn provides pharmaceutical and medical device companies advice on a variety of federal and state regulatory matters.
Significant FDA Digital Health Policy Development for Prescription Drug Sponsors
Inside FDA’s Latest Digital Health Developments: Gottlieb Sees “Vast Potential” Ahead
Key Takeaways from Covington’s Webinar about Digital Health Associated with Pharmaceuticals
The Evolving FDA and EU Equivalent Regulation of Digital Health: A Device Perspective
FDA Initiates Software Precertification Pilot Program
FDA Releases Details and Timelines in Its Digital Health Innovation Action Plan
FTC Releases Online Tool to Help Health App Developers Identify Applicable Laws
FDA to Focus on “Complementary” Diagnostics in Addition to Companion Diagnostics
About
Christina Kuhn provides pharmaceutical and medical device companies advice on a variety of federal and state regulatory matters.